Determination of the contents and related substances of Cefriaxone sodium / Tazobactam sodium for injection by HPLC
Qian Li, Ying Liu, Yao Yongqing, Drug Control
Abstract
Qian Li, Ying Liu, Yao Yongqing, Drug Control
Abstract
OBJECTIVE To establish an HPLC method for the determination of the contents and related substances of Cefriaxone sodium / Tazobactam sodium for injection. METHODS An Kromasil C18column( 250 mm × 4. 6 mm,5 μm) was used. The mobile phase was phosphate buffer solution- acetonitrile( 90∶10). The flow rate was 1. 0 m L·min- 1,the column temperature was 30 ℃ and the detection wavelength was 230 nm. RESULTS In terms of contents,the caliblation curve for Tazobactam was linear in the range of0. 05 to 0. 40 mg·m L- 1( r = 0. 9999). The RSD of repeatability was 1. 5%; the average recovery was 101. 0% and the quantitative limit was 0. 12 μg. The caliblation curve for Ceftriaxone was linear in the range of 0. 15 to 1. 20 mg·m L- 1( r = 0. 9999). The RSD of precision was 0. 5%,the average recovery was 100. 9% and the quantitative limit was 0. 04 μg. In terms of related substances,the caliblation curve for Tazobactam was linear in the range of 2. 5 to 25. 3 μg·m L- 1( r = 0. 9999). The RSD of precision was 2. 0% and the detection limit was 0. 04 μg. The caliblation curve for Cefriaxone was linear in the range of 7. 5 to 75. 0 μg·m L- 1( r = 0. 9999). The RSD of precision was 0. 5% and the detection limit was 0. 01 μg. Every two peaks of each impurity with Ceftriaxone and Tazobactam could be completely separated. CONCLUSION Through the methodology validation,the method is a new reliable analytical method for the quality control of Cefriaxone sodium / Tazobactam sodium for injection.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
OBJECTIVE To establish an HPLC method for the determination of the contents and related substances of Cefriaxone sodium / Tazobactam sodium for injection. METHODS An Kromasil C18column( 250 mm × 4. 6 mm,5 μm) was used. The mobile phase was phosphate buffer solution- acetonitrile( 90∶10). The flow rate was 1. 0 m L·min- 1,the column temperature was 30 ℃ and the detection wavelength was 230 nm. RESULTS In terms of contents,the caliblation curve for Tazobactam was linear in the range of0. 05 to 0. 40 mg·m L- 1( r = 0. 9999). The RSD of repeatability was 1. 5%; the average recovery was 101. 0% and the quantitative limit was 0. 12 μg. The caliblation curve for Ceftriaxone was linear in the range of 0. 15 to 1. 20 mg·m L- 1( r = 0. 9999). The RSD of precision was 0. 5%,the average recovery was 100. 9% and the quantitative limit was 0. 04 μg. In terms of related substances,the caliblation curve for Tazobactam was linear in the range of 2. 5 to 25. 3 μg·m L- 1( r = 0. 9999). The RSD of precision was 2. 0% and the detection limit was 0. 04 μg. The caliblation curve for Cefriaxone was linear in the range of 7. 5 to 75. 0 μg·m L- 1( r = 0. 9999). The RSD of precision was 0. 5% and the detection limit was 0. 01 μg. Every two peaks of each impurity with Ceftriaxone and Tazobactam could be completely separated. CONCLUSION Through the methodology validation,the method is a new reliable analytical method for the quality control of Cefriaxone sodium / Tazobactam sodium for injection.
Key concepts: Chemistry, Detection limit, Chromatography, Repeatability, Calibration curve, High-performance liquid chromatography, Linear range, Phosphate buffered saline